TRAF3IP2 Antikörper (AA 225-241)
Kurzübersicht für TRAF3IP2 Antikörper (AA 225-241) (ABIN208280)
Target
Alle TRAF3IP2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 225-241
-
Spezifität
- An approx. 60 kD band is observed.
-
Homologie
- Percent identity by BLAST analysis: Human, Gorilla, Monkey, Marmoset, Panda (100%) Gibbon, Dog, Elephant (94%) Bovine, Hamster, Horse (88%) Mouse, Rat, Bat, Pig (82%).
-
Aufreinigung
- Protein G purified
-
Immunogen
-
This antibody was developed against a synthetic peptide (QDLPRPLRSREFPQFEP) corresponding to amino acids 225-241 of human CIKS, GeneID: 10758 TRAF3IP2 It will cross react with mouse and rat CIKS. Percent identity by BLAST analysis: Human, Gorilla, Monkey, Marmoset, Panda (100%), Gibbon, Dog, Elephant (94%), Bovine, Hamster, Horse (88%), Mouse, Rat, Bat, Pig (82%).
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: WB (1 - 2 μg/mL)
Not recommended for: IHC-P -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, 0.05 % BSA, 0.05 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- avoid freeze thaw cycles. Store undiluted.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Short term 4°C, long term aliquot and store at -20°C, avoid freeze-thaw cycles. Store undiluted.
-
-
- TRAF3IP2 (TRAF3 Interacting Protein 2 (TRAF3IP2))
-
Andere Bezeichnung
- TRAF3IP2 / ACT1
-
Hintergrund
-
Name/Gene ID: TRAF3IP2
Synonyms: TRAF3IP2, C6orf2, C6orf4, C6orf5, CIKS, DKFZP586G0522, Connection to IKK and SAPK/JNK, ACT1, Adapter protein CIKS, NFkB-activating protein ACT1, PSORS13, TRAF3-interacting protein 2, C6orf6, TRAF3 interacting protein 2 -
Gen-ID
- 10758
-
UniProt
- O43734
-
Pathways
- Production of Molecular Mediator of Immune Response
Target
-